However reports that two splice variants of AGR2 (Δ 6 and Δ 4-6) are selectivity expressed in distinct hepatocellular neoplasms [15] provided hints that analyzing prostate cancer specific splice variants of AGR2 might improve the specificity of this biomarker. The gene discussed is AGR2; the disease is prostate cancer.